Universiteit Leiden

nl en


Reimagining druggability using chemoproteomic platforms

Thursday 28 September 2023
Gorlaeus Building
Einsteinweg 55
2333 CC Leiden
Havinga Lecture Hall (LMUY)

We are pleased to announce that Prof. Dan Nomura will give the first LED3 Lecture of this academic year on September 28th, 2023. Daniel Nomura is Professor of Chemical Biology at UC Berkeley and director of the Novartis-Berkeley Translational Chemical Biology Institute.

His group is world-renowned for their work on expanding the druggable proteome. Here, they have e.g. made important contributions to identifying ligandable hotspots on hard-to-drug targets using chemoproteomics and to developing new protein degraders and stabilizers. Next to his academic excellence, Dan Nomura is also actively engaged in the valorization if his research e.g. as co-founder of Frontier Medicines and founder of Vicinitas Therapeutics.

This website uses cookies.  More information.